Coiled-Coil and C2 Domain-Containing Protein 1A (CC2D1A) Promotes Chemotherapy Resistance in Ovarian Cancer

Coiled-Coil and C2 Domain-Containing Protein 1A (CC2D1A) Promotes Chemotherapy Resistance in Ovarian Cancer

Recurrence within 6 months of the last round of chemotherapy is clinically defined as platinum-resistant ovarian cancer. Gene expression associated with early recurrence may provide insights into platinum resistant recurrence. Prior studies identified a 14-gene model that accurately predicted early...

Full description

Bibliographic Details
Main Authors: Sanjeev Kumar, Derek B. Oien, Ashwani Khurana, William Cliby, Lynn Hartmann, Jeremy Chien, Viji Shridhar
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-10-01
Series:Frontiers in Oncology
Subjects:
CC2D1A
Freud1
ovarian cancer
prognostic marker
chemotherapy resistance
treatment-refractory tumor
Online Access:https://www.frontiersin.org/article/10.3389/fonc.2019.00986/full

Internet

https://www.frontiersin.org/article/10.3389/fonc.2019.00986/full

Similar Items